Abattis Bioceuticals Corp.

Abattis Comments on Recent Market Activity

Abattis Announces Letter of Intent to Acquire Winston Resources

Abattis Bioceuticals Gets Added to the Marijuana Index by MJIC

Abattis Announces the Appointment of New Independent Director

Abattis Executes Memorandum of Agreement to Acquire 100% of Experion Biotechnologies Inc.

Abattis Signs MOU with Global Damon Pharma of South Korea

Abattis’ Northern Vine Labs Receives Controlled Substance Licence

Abattis Names Michael Yung as Ceo

Abattis Announces Co-Formulation with Vitagum(TM)

Abattis Receives NPN from Health Canada for Phyto(NOS)(TM)

Abattis Agrees to License Its NOXX Botanical Blends Products

Abattis Subsidiary, Vergence, Announces First Product in Lineup Now Available for Sale